Cobalt-alkyne complexes with imidazoline ligands as estrogenic carriers: synthesis and pharmacological investigations

J Med Chem. 2008 Nov 27;51(22):7318-22. doi: 10.1021/jm8008376.

Abstract

We synthesized (4R,5S)/(4S,5R)-N-propargyl-4,5-bis(2-chloro-4-methoxy/hydroxyphenyl)-2-imidazolines (1 and 2) as estrogenic carriers for the dicobalthexacarbonyl fragment. The OH-substituted ligand 2 and its related complex 2-Co(2)(CO)(6) showed estrogenic activity in a transcriptional assay in ERalpha-containing MCF-7-2a cells. The cytotoxicity against breast cancer cell lines was more pronounced for the related O-methyl derivative 1-Co(2)(CO)(6). Further pharmacological investigations were performed on the cellular uptake into MCF-7 and MDA-MB-231 cells, the ability of binding to DNA, and the inactivation by HSA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkynes / chemistry*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cobalt / chemistry*
  • DNA / metabolism
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Estrogen Receptor alpha / metabolism
  • Estrogens / chemistry*
  • Humans
  • Imidazolines / chemistry*
  • Ligands
  • Molecular Structure
  • Organometallic Compounds / chemical synthesis*
  • Organometallic Compounds / chemistry
  • Organometallic Compounds / pharmacology*
  • Stereoisomerism
  • Time Factors

Substances

  • Alkynes
  • Estrogen Receptor alpha
  • Estrogens
  • Imidazolines
  • Ligands
  • Organometallic Compounds
  • Cobalt
  • DNA